
Absci’s Upcoming Presentation at the Guggenheim Securities SMID Cap Biotech Conference: A Detailed Look
Absci Corporation’s Participation in the Guggenheim Securities SMID Cap Biotech Conference On January 22, 2025, Absci Corporation (Nasdaq: ABSI), a pioneering biotech company specializing in data-first generative AI drug creation, announced its upcoming participation in the Guggenheim Securities SMID Cap Biotech Conference in New York, NY. This conference is a highly-anticipated event in the biotech…